The Multi-target Effects of CNI-1493: Convergence of Antiamylodogenic and Antiinflammatory Properties in Animal Models of Alzheimer’s Disease

After several decades of Alzheimer’s disease (AD) research and failed clinical trials, one can speculate that targeting a single pathway is not sufficient. However, a cocktail of novel therapeutics will constitute a challenging clinical trial. A more plausible approach will capitalize on a drug that...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Mol Med
Autori principali: Sankowski, Roman, Herring, Arne, Keyvani, Kathy, Frenzel, Kathrin, Wu, Jinyu, Röskam, Stephan, Noelker, Carmen, Bacher, Michael, Al-Abed, Yousef
Natura: Artigo
Lingua:Inglês
Pubblicazione: Feinstein Institute for Medical Research 2016
Soggetti:
Research Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5193463/
https://ncbi.nlm.nih.gov/pubmed/27847962
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2119/molmed.2016.00163
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi